Gary, I have to admire your continued optimism and positivity, especially considering your age and the health challenges you've had to deal with. I'm your age, but my challenges have been minor compared to yours, but I find myself less patient or forgiving than before, one of the reasons I check on the board less. Too much speculation and opinions offered with little fact to base them on. My expectations are limited to things I reasonably believe should happen this year. First, hopefully the FHMA approval, probably in June or July. Second, upon FHMA approval, immediately filing for approval EMA and FDA approval, decisions hopefully by year end but probably early 2025. Lastly, EDEN completion and filing for approvals sometime in the 2nd half of this year, but approval could slip into 2025. I don't expect anything from the lawsuit until 2025 - the law moves too slow, too many possible appeals and actions, and no incentive for the MMs to settle quickly. Won't speculate on the impact on share price on any of these things, but hopefully considerably higher. Don't see any sense in speculating on any of the other possibilities discussed by some.
I do keep some shares in one account available for lending just to track the action. They were lent out about a month ago but returned this week. Don't know if that signifies anything, but interesting.
Your input is appreciated as always.
News 
Market Data 
Discover 
